Neonatal infection in premature infants and use of human immunoglobulin

In an open study 120 consecutively admitted premature babies of 32 weeks' gestation or less, were randomised to receive weekly intramuscular injections of human normal immunoglobulin (50 mg/kg). There was no significant difference between the number of babies in the treated and untreated groups...

Full description

Saved in:
Bibliographic Details
Published in:Archives of disease in childhood 1987-12, Vol.62 (12), p.1252-1256
Main Authors: Conway, S P, Gillies, D R, Docherty, A
Format: Article
Language:English
Subjects:
Bacterial Infections - immunology
Bacterial Infections - prevention & control
Biological and medical sciences
General aspects
Human infectious diseases. Experimental studies and models
Humans
Immunization, Passive
Immunoglobulin G - analysis
Infant, Newborn
Infant, Premature, Diseases - immunology
Infant, Premature, Diseases - prevention & control
Infectious diseases
Medical sciences
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In an open study 120 consecutively admitted premature babies of 32 weeks' gestation or less, were randomised to receive weekly intramuscular injections of human normal immunoglobulin (50 mg/kg). There was no significant difference between the number of babies in the treated and untreated groups who had at least one episode of infection, but the total number of infective episodes was substantially less in the treated group (n = 22) compared with 40 in the non-treated group. Three babies died from overwhelming infection and three babies developed necrotising enterocolitis, all in the group that had not been treated. Serum IgG concentrations were significantly higher in the treated group by the age of 2 weeks but remained consistently below those of full term babies of similar postnatal age. Administration of human immunoglobulin may decrease the severity of infection in premature babies, but alternative regimens may be more successful.
ISSN:0003-9888
1468-2044
DOI:10.1136/adc.62.12.1252